Skip to main content
. 2023 Nov 16;46(2):170–180. doi: 10.1097/FTD.0000000000001154

TABLE 2.

Checklist of Information for Population Pharmacokinetic Studies*

Model Reference and Items Alfaro et al61 Bez et al59 Jiménez-Fernández et al63 Kumra et al7 Piscitelli et al62 Schulz et al58 Wohkittel et al60 Item Compliance Rate (%)
Title/abstract
 Drug and patient population graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg 100
 Name of the drug(s) studied graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg 100
 Route of administration graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i002.jpg 0
 Population studied graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg 100
 Primary objective graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg 85.7
 Major findings graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg 71.4
Background
 Pharmacokinetic data graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i002.jpg 0
 Study rationale graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg 85.7
 Special objectives/hypotheses graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg 71.4
Discussion/conclusion
 Study limitations graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i002.jpg graphic file with name tdm-46-170-i001.jpg 42.9
 Study findings graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg graphic file with name tdm-46-170-i001.jpg 100
Study compliance rate (%) 8/11
72.7
5/11
45.5
5/11
45.5
9/11
81.8
9/11
81.8
8/11
72.7
9/11
81.8
*

Following the recommendations of the study in Clinical Pharmacokinetics by Kanji et al53